Pluvicto 1000 MBq/ml, Injektions-/Infusionslösung

7680686840010 CH-68684 Injektions-/Infusionslösung
Pluvicto 1000 MBq/ml, Injektions-/Infusionslösung
Pluvicto 1000 MBq/ml, Injektions-/Infusionslösung
Pluvicto 1000 MBq/ml, Injektions-/Infusionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektions-/Infusionslösung
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
26/08/2025
Summary of Product Characteristics
Français
26/08/2025
Summary of Product Characteristics
Italien
26/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
1000.0 MBQ Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
7.1 MG Substance HBESI

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
68684
Drug name
Pluvicto, Injektions-/Infusionslösung
Galenic form
LSIN
ATC Code
V10XX05
Authorization status
Z
Dispensing category
A
First authorization
24/02/2023
Authorization expiration date
23/02/2028
IT Number
17.02.
Domain
Human medicine
Field of application
metastasiertem Prostatakrebs, Kastrationsresistenz, PSMA-Positiv

Package details

Description (FR)
PLUVICTO sol inj 1000 MBq/ml flac
Description (DE)
PLUVICTO Inj Lös 1000 MBq/ml Durchstf
Market launch
24/02/2023
Narcotic (BTM)
No